<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1006207</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-16-02314</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pearls</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Fungi</subject><subj-group><subject>Cryptococcus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Infectious diseases of the nervous system</subject><subj-group><subject>Cryptococcal meningitis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Infectious diseases of the nervous system</subject><subj-group><subject>Cryptococcal meningitis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Fungal diseases</subject><subj-group><subject>Yeast infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogenesis</subject><subj-group><subject>Host-pathogen interactions</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antifungals</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial control</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antifungals</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Antifungals</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Immune correlates of HIV-associated cryptococcal meningitis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Tenforde</surname>
<given-names>Mark W.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8463-7137</contrib-id>
<name name-style="western">
<surname>Scriven</surname>
<given-names>James E.</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Harrison</surname>
<given-names>Thomas S.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jarvis</surname>
<given-names>Joseph N.</given-names>
</name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Liverpool School of Tropical Medicine, Liverpool, United Kingdom</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Institute for Infection and Immunity, St George’s, University of London, London, United Kingdom</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>St George’s University Hospitals NHS Foundation Trust, London, United Kingdom</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Botswana-UPenn Partnership, Gaborone, Botswana</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>Department of Clinical Research, Faculty of Infectious Diseases and Tropical Medicine, London School of Hygiene and Tropical Medicine, London, United Kingdom</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Sheppard</surname>
<given-names>Donald C.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>McGill University, CANADA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">mark.tenforde@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<elocation-id>e1006207</elocation-id>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Tenforde et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1006207"/>
<funding-group>
<funding-statement>This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008), to JNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<page-count count="8"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Cryptococcal meningitis (CM) is the leading cause of meningitis in much of sub-Saharan Africa, where it causes up to 20% of all deaths in human immunodeficiency virus (HIV)-infected cohorts [<xref ref-type="bibr" rid="ppat.1006207.ref001">1</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref002">2</xref>]. It is primarily caused by infection with <italic>Cryptococcus neoformans</italic>, an encapsulated yeast found widely in the environment. CM may also be caused by <italic>C</italic>. <italic>gattii</italic>, a related organism with a more limited geographic distribution but with the capacity to cause disease in nonimmunocompromised hosts [<xref ref-type="bibr" rid="ppat.1006207.ref003">3</xref>]. Following inhalation of spores or desiccated yeast cells, an asymptomatic pulmonary infection occurs in the vast majority of immunocompetent hosts, with detectable antibody responses to <italic>Cryptococcus</italic> protein extract by early childhood [<xref ref-type="bibr" rid="ppat.1006207.ref004">4</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref005">5</xref>]. The host immune response leads to clearance of infection or to latent infection with yeast encased within pulmonary granulomata [<xref ref-type="bibr" rid="ppat.1006207.ref006">6</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref007">7</xref>]. If the host immune response is impaired, however, yeasts may survive and disseminate through the body hematogenously, resulting in a severe meningoencephalitis (<xref ref-type="fig" rid="ppat.1006207.g001">Fig 1</xref>) [<xref ref-type="bibr" rid="ppat.1006207.ref003">3</xref>].</p>
<fig id="ppat.1006207.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006207.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Summary of immune responses to <italic>Cryptococcus</italic> in immune competent hosts and in HIV-infected individuals.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006207.g001" xlink:type="simple"/>
</fig>
<p>The host immune response is central to the pathogenesis of cryptococcosis. Not only does an impaired immune response predispose to the condition but variations in the phenotype of the immune response also appear to influence the outcome. Additionally, efforts to reverse the severe immune deficiency through the initiation of antiretroviral therapy (ART) may be complicated by aberrant proinflammatory reactions such as the immune reconstitution inflammatory syndrome (IRIS).</p>
</sec>
<sec id="sec002">
<title>What is the normal host immune response to <italic>Cryptococcus</italic>?</title>
<p>Alveolar macrophages constitute a primary first-line host defense and recognize <italic>Cryptococcus</italic> spores via Dectin-1 receptors [<xref ref-type="bibr" rid="ppat.1006207.ref005">5</xref>]. Phagocytosis occurs through antibody- and complement-mediated, opsonin-dependent pathways and non-opsonin-dependent interaction of cryptococcus surface epitopes with receptors including mannose, dectin-1, CD14, and Toll-like receptor 4 [<xref ref-type="bibr" rid="ppat.1006207.ref008">8</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref009">9</xref>]. Once internalized, yeast-containing phagosomes fuse with lysosomes, and intracellular killing may occur under the influence of interferon-γ (IFN-γ) produced by natural killer cells and CD4 T cells [<xref ref-type="bibr" rid="ppat.1006207.ref010">10</xref>]. However, in some circumstances and in the absence of appropriate macrophage activation, cryptococci can survive and replicate within the phagolysosome, protected through a variety of mechanisms, including expansion of its thick polysaccharide capsule and laccase-induced melanin synthesis that may neutralize free radicals. Cryptococci eventually exit the macrophage through cell lysis, actin-dependent direct cell-to-cell transfer, or non–lytic exocytosis [<xref ref-type="bibr" rid="ppat.1006207.ref011">11</xref>–<xref ref-type="bibr" rid="ppat.1006207.ref013">13</xref>]. Parasitism of macrophages facilitate replication and may also facilitate migration of yeast to the central nervous system (CNS) [<xref ref-type="bibr" rid="ppat.1006207.ref008">8</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref014">14</xref>].</p>
</sec>
<sec id="sec003">
<title>What are major susceptibility factors for the development of cryptococcal meningitis in humans?</title>
<p>Cryptococcosis occurs almost exclusively in individuals with impaired cell-mediated immunity. The vast majority of cases worldwide are associated with advanced HIV infection, illustrating the vital importance of CD4 T cells in the human host response [<xref ref-type="bibr" rid="ppat.1006207.ref015">15</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref016">16</xref>]. Other risk factors include solid organ transplantation, long-term use of immunosuppressive drugs, diabetes mellitus, rheumatological diseases, advanced liver and renal disease, and hematological malignancies [<xref ref-type="bibr" rid="ppat.1006207.ref017">17</xref>]. In addition, a number of rare genetic conditions have been linked to cryptococcosis in non-HIV-infected patients [<xref ref-type="bibr" rid="ppat.1006207.ref018">18</xref>].</p>
<p>Despite presumed frequent environmental exposure, not all individuals with deficient cell-mediated immunity, as found in late-stage HIV infection, develop disseminated cryptococcosis. This suggests there may be additional factors that influence host susceptibility. Phagocytic Fcγ receptor 3A 158 F/V polymorphisms have recently been found to be a risk factor for cryptococcal disease, with FcγR3A VV homozygosity conferring higher risk, as have the presence of autoantibodies against granulocyte macrophage colony stimulating factor (GM-CSF) [<xref ref-type="bibr" rid="ppat.1006207.ref018">18</xref>–<xref ref-type="bibr" rid="ppat.1006207.ref020">20</xref>]. Additional genetic studies comparing DNA from patients with HIV-associated cryptococcal meningitis with that from population and CD4 cell count-matched individuals without evidence of cryptococcal infection are underway. Among exposed individuals, heterogeneity in <italic>Cryptococcus</italic> sequence type, genotype, and phenotype also influence the ability of yeast to disseminate and the clinical outcome [<xref ref-type="bibr" rid="ppat.1006207.ref021">21</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref022">22</xref>].</p>
</sec>
<sec id="sec004">
<title>How does the immune phenotype in HIV-associated cryptococcal meningitis influence outcome?</title>
<p>Proinflammatory and Th1-type immune responses are beneficial among patients with HIV-associated CM, while a lack of immune response is detrimental. Studies from cohorts of patients with HIV-associated CM have shown that higher baseline concentrations of IFN-γ, TNF-α, and IL-6 in the CSF are associated with lower CSF fungal burden, faster fungal clearance on antifungal therapy, and improved survival [<xref ref-type="bibr" rid="ppat.1006207.ref023">23</xref>–<xref ref-type="bibr" rid="ppat.1006207.ref026">26</xref>]. However, this does not appear to simply be a correlate of a higher CD4 T cell count. Flow–cytometric analyses have suggested that the CD4 T cell phenotype, rather than just the number of circulating CD4 cells, is important in determining the outcome of CM. Following stimulation with cryptococcal mannoprotein, patients with IFN-γ- and/or TNF-α-producing CD4 T cells had corresponding higher CSF lymphocyte counts and CSF cytokine levels, along with lower CSF fungal burden and improved two-week survival odds [<xref ref-type="bibr" rid="ppat.1006207.ref027">27</xref>].</p>
<p>Further study has shown that the impaired Th1 response observed in nonsurvivors is not an isolated immune defect but one component of a widespread systemic deactivation of the immune system characterized by monocyte deactivation (decreased human leukocyte antigen [HLA]-DR expression and decreased production of TNF-α following stimulation with lipopolysaccharide); raised IL-10, IL-6, and CXCL10; and increased circulating neutrophils [<xref ref-type="bibr" rid="ppat.1006207.ref028">28</xref>]. This immune signature was an independent predictor of two-week mortality and correlated with plasma concentrations of the cryptococcal polysaccharide antigen glucuronoxylomannan (GXM), suggesting that the immune deactivation observed in nonsurvivors may be the result of immunomodulatory actions of <italic>Cryptococcus</italic>. This hypothesis is supported by in vitro studies demonstrating that GXM impairs monocyte activation and antigen presentation and subsequent T cell responses via an IL-10-dependent mechanism [<xref ref-type="bibr" rid="ppat.1006207.ref029">29</xref>].</p>
<p>Findings in humans are broadly consistent with animal studies demonstrating protective effects of Th1 immune responses, characterized by IFN-γ production and classically activated macrophages, and detrimental effects of Th2-type responses [<xref ref-type="bibr" rid="ppat.1006207.ref030">30</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref031">31</xref>]. However, human studies have not convincingly demonstrated the Th1/Th2 dichotomy found in murine studies. Th2 cytokines (IL-4, IL-13) are less readily detectable in the CSF and are often closely correlated with Th1 cytokines (IFN-γ). [<xref ref-type="bibr" rid="ppat.1006207.ref026">26</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref027">27</xref>] This may simply be due to biological differences between species. However, it may also reflect the time course of the immune response. Murine studies typically evaluate the acute immune response following pulmonary inoculation with <italic>Cryptococcus</italic>, whereas human studies represent patients with subacute infection who have a dynamic and evolving host response.</p>
</sec>
<sec id="sec005">
<title>Does modulation of the immune response improve outcome in CM?</title>
<p>Two main strategies have been adopted to improve host immune response in HIV-associated CM. The first is the use of adjunctive immunotherapy alongside antifungal therapy. IFN-γ has been tested in two phase-2 trials and was found to be safe and associated with a faster rate of CSF fungal clearance. [<xref ref-type="bibr" rid="ppat.1006207.ref032">32</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref033">33</xref>] Subgroup analyses suggested that the greatest benefit was gained among patients with a lack of cryptococcus-specific IFN-γ/TNF-α T cell responses. [<xref ref-type="bibr" rid="ppat.1006207.ref027">27</xref>]. Neither of these phase-2 trials were sufficiently powered to examine mortality differences; and larger phase-3 trials to determine the mortality benefits of adjunctive IFN-γ therapy, while justified, have not yet been conducted. The second strategy is augmentation of the immune response through earlier initiation of ART. Despite success in the setting of other opportunistic infections [<xref ref-type="bibr" rid="ppat.1006207.ref034">34</xref>], this appears not to be beneficial in CM. Two randomized clinical trials have shown increased mortality with early ART. The first showed increased mortality when ART was initiated at 72 hours compared to 10 weeks following CM diagnosis in fluconazole-treated patients [<xref ref-type="bibr" rid="ppat.1006207.ref035">35</xref>]. The second, conducted in Uganda and South Africa using amphotericin B-based antifungal therapy, showed increased mortality with ART initiation at 7–13 days compared to 5–6 weeks following CM diagnosis [<xref ref-type="bibr" rid="ppat.1006207.ref023">23</xref>]. It was hypothesized that the increased mortality might have been due the development of undiagnosed IRIS.</p>
<p>Immune modulation with adjunctive dexamethasone has also been tested for treatment of CM in a phase-3 trial [<xref ref-type="bibr" rid="ppat.1006207.ref036">36</xref>]. This study was terminated early after dexamethasone use was associated with slower fungal clearance from the CSF, higher rates of disability, and a trend toward higher mortality. The immunological mechanisms underlying these findings are not yet known.</p>
</sec>
<sec id="sec006">
<title>What is cryptococcal immune reconstitution inflammatory syndrome?</title>
<p>IRIS is defined as “a paradoxical deterioration in clinical status attributable to the recovery of the immune system” and in HIV typically manifests as inflammatory reactions at the site of previously treated or previously unrecognized opportunistic infections following the initiation of ART [<xref ref-type="bibr" rid="ppat.1006207.ref037">37</xref>]. Cryptococcal IRIS (C-IRIS) is reported to occur in 10%–20% of individuals with HIV-associated CM at a median of 4–9 weeks following ART initiation and has been identified as an independent predictor of mortality [<xref ref-type="bibr" rid="ppat.1006207.ref025">25</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref038">38</xref>–<xref ref-type="bibr" rid="ppat.1006207.ref040">40</xref>]. The usual presentation is with a recurrence of signs and symptoms of meningitis [<xref ref-type="bibr" rid="ppat.1006207.ref041">41</xref>]. Immunological studies have reported a CSF immune response characterized by a CD4 T cell infiltrate, a proinflammatory monocyte phenotype, and increased concentrations of proinflammatory cytokines (TNF-α, IFN-γ, granulocyte colony stimulating factor) [<xref ref-type="bibr" rid="ppat.1006207.ref042">42</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref043">43</xref>].</p>
<p>The risk of developing C-IRIS appears to be closely related to the host immune response during the initial episode of CM. Individuals with a lack of inflammation in their CSF during the initial episode of CM, characterized by low CSF white cells (&lt;5/μL), low CSF concentrations of proinflammatory cytokines (IFN-γ, TNF-α, IL-6, IL-8), and increased concentrations of CSF chemokines (CCL2/MCP-1, CCL3/MIP-1α) are at high risk of developing IRIS following ART initiation [<xref ref-type="bibr" rid="ppat.1006207.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref044">44</xref>]. Pre-ART cryptococcus-induced IFN-γ production from whole blood is also reduced in those who go on to develop C-IRIS [<xref ref-type="bibr" rid="ppat.1006207.ref045">45</xref>]. This paucity of immune response is associated with a higher CSF fungal burden at baseline, slower fungal clearance on antifungal therapy, and increased CSF fungal burdens at the end of antifungal therapy [<xref ref-type="bibr" rid="ppat.1006207.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref046">46</xref>]. This increased residual cryptococcal antigen load probably drives C-IRIS during CD4 recovery on ART, with the elevated chemokine levels leading to excessive trafficking of immune cells into the CSF [<xref ref-type="bibr" rid="ppat.1006207.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref044">44</xref>, <xref ref-type="bibr" rid="ppat.1006207.ref046">46</xref>–<xref ref-type="bibr" rid="ppat.1006207.ref049">49</xref>].</p>
<p>Although no increase in cases of IRIS was observed in the early ART trials, it is probable that the excess mortality was immunologically mediated. The increased mortality associated with early ART was primarily driven by individuals with a CSF white cell count (WCC) &lt;5/γL at randomization—the same group found to be at the highest risk of developing IRIS [<xref ref-type="bibr" rid="ppat.1006207.ref023">23</xref>]. Further analysis has shown that early ART was associated with an influx of inflammatory cells into the CSF, with significantly more patients in the early ART arm developing CSF pleocytosis (WCC ≥5/μL) by day 14 (after a median of six days of ART), accompanied by increased CSF concentrations of soluble CD14 and CD163, suggesting increased macrophage activation in the CSF [<xref ref-type="bibr" rid="ppat.1006207.ref049">49</xref>].</p>
</sec>
<sec id="sec007" sec-type="conclusions">
<title>Conclusion</title>
<p>Cryptococcal meningitis has emerged as a leading cause of death in individuals with impaired CD4 T cell-mediated immunity. Recent human data suggests that an absence of an effective Th1 response, characterized by IFN-γ and TNF-α production, leads to monocyte deactivation, excessive CNS chemokine production, and poor clearance of infection with increased risk of IRIS and death. Immunomodulation with steroid therapy increases the risk of a poor outcome, whereas augmentation with IFN-γ has demonstrated benefits in faster fungal clearance when coupled with effective antifungal therapy.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="ppat.1006207.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Crede</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>. <article-title>Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases</article-title>. <source>BMC Infect Dis</source>. <year>2010</year>;<volume>10</volume>:<fpage>67</fpage>. PMCID: 3161361. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2334-10-67" xlink:type="simple">10.1186/1471-2334-10-67</ext-link></comment> <object-id pub-id-type="pmid">20230635</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lawn</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Harries</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Anglaret</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Myer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>R</given-names></name>. <article-title>Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa</article-title>. <source>Aids</source>. <year>2008</year>;<volume>22</volume>(<issue>15</issue>):<fpage>1897</fpage>–<lpage>908</lpage>. PMCID: PMC3816249. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e32830007cd" xlink:type="simple">10.1097/QAD.0b013e32830007cd</ext-link></comment> <object-id pub-id-type="pmid">18784453</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>. <article-title>HIV-associated cryptococcal meningitis</article-title>. <source>AIDS (London, England)</source>. <year>2007</year>;<volume>21</volume>(<issue>16</issue>):<fpage>2119</fpage>–<lpage>29</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldman</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Khine</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Abadi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lindenberg</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Pirofski</surname> <given-names>La</given-names></name>, <name name-style="western"><surname>Niang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Casadevall</surname> <given-names>A</given-names></name>. <article-title>Serologic evidence for Cryptococcus neoformans infection in early childhood</article-title>. <source>Pediatrics</source>. <year>2001</year>;<volume>107</volume>(<issue>5</issue>):<fpage>E66</fpage>. <object-id pub-id-type="pmid">11331716</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giles</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Dagenais</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Botts</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Keller</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>Hull</surname> <given-names>CM</given-names></name>. <article-title>Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans</article-title>. <source>Infection and immunity</source>. <year>2009</year>;<volume>77</volume>(<issue>8</issue>):<fpage>3491</fpage>–<lpage>500</lpage>. Epub 2009/05/20. PMCID: 2715683. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00334-09" xlink:type="simple">10.1128/IAI.00334-09</ext-link></comment> <object-id pub-id-type="pmid">19451235</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldman</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Mednick</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Montella</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Casadevall</surname> <given-names>A</given-names></name>. <article-title>Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide</article-title>. <source>Infection and immunity</source>. <year>2000</year>;<volume>68</volume>(<issue>2</issue>):<fpage>832</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">10639453</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baker</surname> <given-names>RD</given-names></name>. <article-title>The primary pulmonary lymph node complex of crytptococcosis</article-title>. <source>American journal of clinical pathology</source>. <year>1976</year>;<volume>65</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>92</lpage>. <object-id pub-id-type="pmid">1246992</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>García-Rodas</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Zaragoza</surname> <given-names>O</given-names></name>. <article-title>Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2012</year>;<volume>64</volume>(<issue>2</issue>):<fpage>147</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1574-695X.2011.00871.x" xlink:type="simple">10.1111/j.1574-695X.2011.00871.x</ext-link></comment> <object-id pub-id-type="pmid">22029633</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levitz</surname> <given-names>SM</given-names></name>. <article-title>Innate recognition of fungal cell walls</article-title>. <source>PLoS Pathog</source>. <year>2010</year>;<volume>6</volume>(<issue>4</issue>):<fpage>e1000758</fpage>. PMCID: PMC2858700. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000758" xlink:type="simple">10.1371/journal.ppat.1000758</ext-link></comment> <object-id pub-id-type="pmid">20421940</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawakami</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kohno</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kadota</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tohyama</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Teruya</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kudeken</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Saito</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hara</surname> <given-names>K</given-names></name>. <article-title>T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection</article-title>. <source>Microbiol Immunol</source>. <year>1995</year>;<volume>39</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>43</lpage>. <object-id pub-id-type="pmid">7783686</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnston</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>May</surname> <given-names>RC</given-names></name>. <article-title>Cryptococcus interactions with macrophages: evasion and manipulation of the phagosome by a fungal pathogen</article-title>. <source>Cell Microbiol</source>. <year>2013</year>;<volume>15</volume>(<issue>3</issue>):<fpage>403</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cmi.12067" xlink:type="simple">10.1111/cmi.12067</ext-link></comment> <object-id pub-id-type="pmid">23127124</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>LT</given-names></name>, <name name-style="western"><surname>Lodge</surname> <given-names>JK</given-names></name>. <article-title>Cryptococcus neoformans, a fungus under stress</article-title>. <source>Curr Opin Microbiol</source>. <year>2007</year>;<volume>10</volume>(<issue>4</issue>):<fpage>320</fpage>–<lpage>5</lpage>. PMCID: PMC2570326. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mib.2007.05.014" xlink:type="simple">10.1016/j.mib.2007.05.014</ext-link></comment> <object-id pub-id-type="pmid">17707685</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levitz</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Nong</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Seetoo</surname> <given-names>KF</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Speizer</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Simons</surname> <given-names>ER</given-names></name>. <article-title>Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages</article-title>. <source>Infection and immunity</source>. <year>1999</year>;<volume>67</volume>(<issue>2</issue>):<fpage>885</fpage>–<lpage>90</lpage>. PMCID: PMC96400. <object-id pub-id-type="pmid">9916104</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sabiiti</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Robertson</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Beale</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Johnston</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Brouwer</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Loyse</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Gilbert</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>May</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>. <article-title>Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis</article-title>. <source>J Clin Invest</source>. <year>2014</year>;<volume>124</volume>(<issue>5</issue>):<fpage>2000</fpage>–<lpage>8</lpage>. PMCID: 4001551. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI72950" xlink:type="simple">10.1172/JCI72950</ext-link></comment> <object-id pub-id-type="pmid">24743149</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Wannemuehler</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Marston</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Govender</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Pappas</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Chiller</surname> <given-names>TM</given-names></name>. <article-title>Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS</article-title>. <source>AIDS (London, England)</source>. <year>2009</year>;<volume>23</volume>(<issue>4</issue>):<fpage>525</fpage>–<lpage>30</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neofytos</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Fishman</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Horn</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Anaissie</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Olyaei</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pfaller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Steinbach</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Webster</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Marr</surname> <given-names>KA</given-names></name>. <article-title>Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients</article-title>. <source>Transplant infectious disease: an official journal of the Transplantation Society</source>. <year>2010</year>;<volume>12</volume>(<issue>3</issue>):<fpage>220</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pappas</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Perfect</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Cloud</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Pankey</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Lancaster</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Henderson</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kauffman</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Haas</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Saccente</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hamill</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Holloway</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Warren</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Dismukes</surname> <given-names>WE</given-names></name>. <article-title>Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy</article-title>. <source>Clin Infect Dis</source>. <year>2001</year>;<volume>33</volume>(<issue>5</issue>):<fpage>690</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/322597" xlink:type="simple">10.1086/322597</ext-link></comment> <object-id pub-id-type="pmid">11477526</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosen</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Freeman</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Jutivorakool</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Olivier</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Angkasekwinai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Suputtamongkol</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Bennett</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Pyrgos</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Holland</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Browne</surname> <given-names>SK</given-names></name>. <article-title>Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis</article-title>. <source>J Immunol</source>. <year>2013</year>;<volume>190</volume>(<issue>8</issue>):<fpage>3959</fpage>–<lpage>66</lpage>. PMCID: PMC3675663. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1202526" xlink:type="simple">10.4049/jimmunol.1202526</ext-link></comment> <object-id pub-id-type="pmid">23509356</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rohatgi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gohil</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kuniholm</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Schultz</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Dufaud</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Armour</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Badri</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mailliard</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Pirofski</surname> <given-names>LA</given-names></name>. <article-title>Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease</article-title>. <source>MBio</source>. <year>2013</year>;<volume>4</volume>(<issue>5</issue>):<fpage>e00573</fpage>–<lpage>13</lpage>. PMCID: PMC3760251. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mBio.00573-13" xlink:type="simple">10.1128/mBio.00573-13</ext-link></comment> <object-id pub-id-type="pmid">23982074</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saijo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Rosen</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Yi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sorrell</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Bennett</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Holland</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Browne</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Kwon-Chung</surname> <given-names>KJ</given-names></name>. <article-title>Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients</article-title>. <source>MBio</source>. <year>2014</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e00912</fpage>–<lpage>14</lpage>. PMCID: PMC3967522. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mBio.00912-14" xlink:type="simple">10.1128/mBio.00912-14</ext-link></comment> <object-id pub-id-type="pmid">24643864</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alanio</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Desnos-Ollivier</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dromer</surname> <given-names>F</given-names></name>. <article-title>Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans</article-title>. <source>MBio</source>. <year>2011</year>;<volume>2</volume>(<issue>4</issue>). PMCID: PMC3149853.</mixed-citation></ref>
<ref id="ppat.1006207.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beale</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Sabiiti</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Robertson</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Fuentes-Cabrejo</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>O'Hanlon</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Loyse</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>May</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>. <article-title>Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>6</issue>):<fpage>e0003847</fpage>. PMCID: PMC4482434. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0003847" xlink:type="simple">10.1371/journal.pntd.0003847</ext-link></comment> <object-id pub-id-type="pmid">26110902</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Muzoora</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rolfes</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Huppler</surname> <given-names>Hullsiek K</given-names></name>, <name name-style="western"><surname>Musubire</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Taseera</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nabeta</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Schutz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Rajasingham</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Rhein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Thienemann</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lo</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bergemann</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Kambugu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Manabe</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Janoff</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Team</surname> <given-names>CT</given-names></name>. <article-title>Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis</article-title>. <source>The New England journal of medicine</source>. <year>2014</year>;<volume>370</volume>(<issue>26</issue>):<fpage>2487</fpage>–<lpage>98</lpage>. 24963568; PMCID: 4127879. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1312884" xlink:type="simple">10.1056/NEJMoa1312884</ext-link></comment> <object-id pub-id-type="pmid">24963568</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kambugu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Rhein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>O'Brien</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Janoff</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Ronald</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Kamya</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Mayanja-Kizza</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sande</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>. <article-title>Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>. <year>2008</year>;<volume>46</volume>(<issue>11</issue>):<fpage>1694</fpage>–<lpage>701</lpage>. PMCID: PMC2593910.</mixed-citation></ref>
<ref id="ppat.1006207.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Loyse</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Namarika</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Jackson</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nussbaum</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Longley</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Muzoora</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Phulusa</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Taseera</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kanyembe</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hosseinipour</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Brouwer</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Limmathurotsakul</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>van der Horst</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bradley</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jaffar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>T</given-names></name>. <article-title>Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes</article-title>. <source>Clin Infect Dis</source>. <year>2014</year>;<volume>58</volume>(<issue>5</issue>):<fpage>736</fpage>–<lpage>45</lpage>. PMCID: 3922213. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cid/cit794" xlink:type="simple">10.1093/cid/cit794</ext-link></comment> <object-id pub-id-type="pmid">24319084</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siddiqui</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Brouwer</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Wuthiekanun</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Jaffar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shattock</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Irving</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sheldon</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chierakul</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Peacock</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Day</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>. <article-title>IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis</article-title>. <source>J Immunol</source>. <year>2005</year>;<volume>174</volume>(<issue>3</issue>):<fpage>1746</fpage>–<lpage>50</lpage>. <object-id pub-id-type="pmid">15661940</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Casazza</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Stone</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lawn</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Levitz</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Koup</surname> <given-names>RA</given-names></name>. <article-title>The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis</article-title>. <source>J Infect Dis</source>. <year>2013</year>;<volume>207</volume>(<issue>12</issue>):<fpage>1817</fpage>–<lpage>28</lpage>. PMCID: PMC3654748. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jit099" xlink:type="simple">10.1093/infdis/jit099</ext-link></comment> <object-id pub-id-type="pmid">23493728</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scriven</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Schutz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Scriba</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Wilkinson</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Wilkinson</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Urban</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Lalloo</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>. <article-title>A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis</article-title>. <source>J Infect Dis</source>. <year>2016</year>;<volume>213</volume>(<issue>11</issue>):<fpage>1725</fpage>–<lpage>34</lpage>. PMCID: PMC4857465. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiw007" xlink:type="simple">10.1093/infdis/jiw007</ext-link></comment> <object-id pub-id-type="pmid">26768248</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Retini</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vecchiarelli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Monari</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bistoni</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kozel</surname> <given-names>TR</given-names></name>. <article-title>Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes</article-title>. <source>Infect Immun</source>. <year>1998</year>;<volume>66</volume>(<issue>2</issue>):<fpage>664</fpage>–<lpage>9</lpage>. PMCID: PMC107954. <object-id pub-id-type="pmid">9453624</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Müller</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Piehler</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Stenzel</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Köhler</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Frey</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Held</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Grahnert</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Richter</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Eschke</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kamradt</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Brombacher</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Alber</surname> <given-names>G</given-names></name>. <article-title>Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis</article-title>. <source>Mucosal Immunol</source>. <year>2012</year>;<volume>5</volume>(<issue>3</issue>):<fpage>299</fpage>–<lpage>310</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mi.2012.9" xlink:type="simple">10.1038/mi.2012.9</ext-link></comment> <object-id pub-id-type="pmid">22333910</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stenzel</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Köhler</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Heppner</surname> <given-names>FL</given-names></name>, <name name-style="western"><surname>Blessing</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>McKenzie</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Brombacher</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Alber</surname> <given-names>G</given-names></name>. <article-title>IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis</article-title>. <source>The American journal of pathology</source>. <year>2009</year>;<volume>174</volume>(<issue>2</issue>):<fpage>486</fpage>–<lpage>96</lpage>. PMCID: PMC2630557. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2353/ajpath.2009.080598" xlink:type="simple">10.2353/ajpath.2009.080598</ext-link></comment> <object-id pub-id-type="pmid">19147811</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rebe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>GN</given-names></name>, <name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schutz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bekker</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>. <article-title>Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial</article-title>. <source>Aids</source>. <year>2012</year>;<volume>26</volume>(<issue>9</issue>):<fpage>1105</fpage>–<lpage>13</lpage>. PMCID: PMC3640254. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e3283536a93" xlink:type="simple">10.1097/QAD.0b013e3283536a93</ext-link></comment> <object-id pub-id-type="pmid">22421244</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pappas</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Bustamante</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ticona</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hamill</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Reboli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hasbun</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>HH</given-names></name>. <article-title>Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis</article-title>. <source>The Journal of infectious diseases</source>. <year>2004</year>;<volume>189</volume>(<issue>12</issue>):<fpage>2185</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/420829" xlink:type="simple">10.1086/420829</ext-link></comment> <object-id pub-id-type="pmid">15181565</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abdool Karim</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Naidoo</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Grobler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Padayatchi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Baxter</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gengiah</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nair</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bamber</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Singh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pienaar</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>El-Sadr</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Friedland</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Abdool Karim</surname> <given-names>Q</given-names></name>. <article-title>Timing of initiation of antiretroviral drugs during tuberculosis therapy</article-title>. <source>The New England journal of medicine</source>. <year>2010</year>;<volume>362</volume>(<issue>8</issue>):<fpage>697</fpage>–<lpage>706</lpage>. PMCID: PMC3076221. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa0905848" xlink:type="simple">10.1056/NEJMoa0905848</ext-link></comment> <object-id pub-id-type="pmid">20181971</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makadzange</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Ndhlovu</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Takarinda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kurangwa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gona</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hakim</surname> <given-names>JG</given-names></name>. <article-title>Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa</article-title>. <source>Clin Infect Dis</source>. <year>2010</year>;<volume>50</volume>(<issue>11</issue>):<fpage>1532</fpage>–<lpage>8</lpage>. Epub 2010/04/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/652652" xlink:type="simple">10.1086/652652</ext-link></comment> <object-id pub-id-type="pmid">20415574</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beardsley</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wolbers</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kibengo</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Ggayi</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Kamali</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cuc</surname> <given-names>NT</given-names></name>, <name name-style="western"><surname>Binh</surname> <given-names>TQ</given-names></name>, <name name-style="western"><surname>Chau</surname> <given-names>NV</given-names></name>, <name name-style="western"><surname>Farrar</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Merson</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Phuong</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Thwaites</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Van Kinh</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Thuy</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Chierakul</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Siriboon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Thiansukhon</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Onsanit</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Supphamongkholchaikul</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Heyderman</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mwinjiwa</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>van Oosterhout</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Imran</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Basri</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Mayxay</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dance</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Phimmasone</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rattanavong</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lalloo</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Day</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Investigators</surname> <given-names>C</given-names></name>. <article-title>Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis</article-title>. <source>The New England journal of medicine</source>. <year>2016</year>;<volume>374</volume>(<issue>6</issue>):<fpage>542</fpage>–<lpage>54</lpage>. PMCID: PMC4778268. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1509024" xlink:type="simple">10.1056/NEJMoa1509024</ext-link></comment> <object-id pub-id-type="pmid">26863355</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shelburne</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Hamill</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Rodriguez-Barradas</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Atmar</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Musher</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Gathe</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Visnegarwala</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Trautner</surname> <given-names>BW</given-names></name>. <article-title>Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy</article-title>. <source>Medicine (Baltimore)</source>. <year>2002</year>;<volume>81</volume>(<issue>3</issue>):<fpage>213</fpage>–<lpage>27</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rebe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Loyse</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hayes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jaffar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>T</given-names></name>. <article-title>Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study</article-title>. <source>Journal of acquired immune deficiency syndromes (1999)</source>. <year>2009</year>;<volume>51</volume>(<issue>2</issue>):<fpage>130</fpage>–<lpage>4</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shelburne</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Darcourt</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Hamill</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Atmar</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Visnegarwala</surname> <given-names>F</given-names></name>. <article-title>The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>. <year>2005</year>;<volume>40</volume>(<issue>7</issue>):<fpage>1049</fpage>–<lpage>52</lpage>.</mixed-citation></ref>
<ref id="ppat.1006207.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sungkanuparph</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Filler</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Chetchotisakd</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pappas</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Nolen</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Manosuthi</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Anekthananon</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Morris</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>Supparatpinyo</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kopetskie</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kendrick</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Sobel</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>RA</given-names></name>. <article-title>Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study</article-title>. <source>Clin Infect Dis</source>. <year>2009</year>;<volume>49</volume>(<issue>6</issue>):<fpage>931</fpage>–<lpage>4</lpage>. Epub 2009/08/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/605497" xlink:type="simple">10.1086/605497</ext-link></comment> <object-id pub-id-type="pmid">19681708</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haddow</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Colebunders</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lawn</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Elliott</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Manabe</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Sungkanuparph</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Easterbrook</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>French</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <collab>(INSHI) INftSoH-aI</collab>. <article-title>Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions</article-title>. <source>Lancet Infect Dis</source>. <year>2010</year>;<volume>10</volume>(<issue>11</issue>):<fpage>791</fpage>–<lpage>802</lpage>. PMCID: PMC3026057. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(10)70170-5" xlink:type="simple">10.1016/S1473-3099(10)70170-5</ext-link></comment> <object-id pub-id-type="pmid">21029993</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Okurut</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zziwa</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rolfes</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Kelsey</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cose</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Joloba</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Naluyima</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Palmer</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Kambugu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mayanja-Kizza</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Eller</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Wahl</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Manabe</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Janoff</surname> <given-names>EN</given-names></name>. <article-title>Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome</article-title>. <source>J Infect Dis</source>. <year>2015</year>;<volume>211</volume>(<issue>10</issue>):<fpage>1597</fpage>–<lpage>606</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiu664" xlink:type="simple">10.1093/infdis/jiu664</ext-link></comment> <object-id pub-id-type="pmid">25492918</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Bonham</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Wiesner</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Kambugu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Janoff</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>. <article-title>Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome</article-title>. <source>The Journal of infectious diseases</source>. <year>2010</year>;<volume>202</volume>(<issue>6</issue>):<fpage>962</fpage>–<lpage>70</lpage>. Epub 2010/08/04. PMCID: 2924457. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/655785" xlink:type="simple">10.1086/655785</ext-link></comment> <object-id pub-id-type="pmid">20677939</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jarvis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bicanic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Buffa</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Hogan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tomlinson</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kropf</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Noursadeghi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Harrison</surname> <given-names>TS</given-names></name>. <article-title>Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis</article-title>. <source>PLoS Pathog</source>. <year>2015</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e1004754</fpage>. PMCID: 4390200. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1004754" xlink:type="simple">10.1371/journal.ppat.1004754</ext-link></comment> <object-id pub-id-type="pmid">25853653</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Omarjee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Levitz</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Gosnell</surname> <given-names>BI</given-names></name>, <name name-style="western"><surname>Spelman</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Elliott</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Carr</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Moosa</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Ndung'u</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lewin</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>French</surname> <given-names>MA</given-names></name>. <article-title>Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy</article-title>. <source>The Journal of infectious diseases</source>. <year>2013</year>;<volume>208</volume>(<issue>6</issue>):<fpage>898</fpage>–<lpage>906</lpage>. PMCID: PMC3749010. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jit271" xlink:type="simple">10.1093/infdis/jit271</ext-link></comment> <object-id pub-id-type="pmid">23766525</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Dorasamy</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Gosnell</surname> <given-names>BI</given-names></name>, <name name-style="western"><surname>Elliott</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Spelman</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Omarjee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Naranbhai</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Coovadia</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ndung'u</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Moosa</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Lewin</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>French</surname> <given-names>MA</given-names></name>. <article-title>Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome</article-title>. <source>Aids</source>. <year>2013</year>;<volume>27</volume>(<issue>13</issue>):<fpage>2089</fpage>–<lpage>99</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e3283614a8d" xlink:type="simple">10.1097/QAD.0b013e3283614a8d</ext-link></comment> <object-id pub-id-type="pmid">23525034</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Bergemann</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Wiesner</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Rhein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Musubire</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Kambugu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Janoff</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Bohjanen</surname> <given-names>PR</given-names></name>. <article-title>Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study</article-title>. <source>PLoS Med</source>. <year>2010</year>;<volume>7</volume>(<issue>12</issue>):<fpage>e1000384</fpage>. Epub 2011/01/22. PMCID: 3014618. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.1000384" xlink:type="simple">10.1371/journal.pmed.1000384</ext-link></comment> <object-id pub-id-type="pmid">21253011</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Omarjee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Spelman</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gosnell</surname> <given-names>BI</given-names></name>, <name name-style="western"><surname>Carr</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Elliott</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Moosa</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Ndung'u</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>French</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Lewin</surname> <given-names>SR</given-names></name>. <article-title>Chemokine Levels and Chemokine Receptor Expression in the Blood and the Cerebrospinal Fluid of HIV-Infected Patients With Cryptococcal Meningitis and Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome</article-title>. <source>The Journal of infectious diseases</source>. <year>2013</year>;<volume>208</volume>(<issue>10</issue>):<fpage>1604</fpage>–<lpage>12</lpage>. PMCID: PMC3805241. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jit388" xlink:type="simple">10.1093/infdis/jit388</ext-link></comment> <object-id pub-id-type="pmid">23908492</object-id></mixed-citation></ref>
<ref id="ppat.1006207.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scriven</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Rhein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hullsiek</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>von Hohenberg</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Linder</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rolfes</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Taseera</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Meya</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Meintjes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Boulware</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Team</surname> <given-names>C</given-names></name>. <article-title>Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial</article-title>. <source>J Infect Dis</source>. <year>2015</year>.</mixed-citation></ref>
</ref-list>
</back>
</article>